首页> 外文OA文献 >Bioavailability and absorption kinetics of nicotine following application of a transdermal system.
【2h】

Bioavailability and absorption kinetics of nicotine following application of a transdermal system.

机译:应用透皮系统后,尼古丁的生物利用度和吸收动力学。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

1. The absolute bioavailability and absorption kinetics of nicotine were investigated in 13 healthy adult male smokers following single and multiple applications of a nicotine transdermal system (NTS), designed to release nicotine at an approximate rate of 1.5 mg h-1 over 24 h. The absorption of nicotine from the single NTS application was calculated with reference to a simultaneous intravenous infusion (i.v.) of deuterium-labelled nicotine. 2. The mean input time (MIT) and mean absorption time (MAT) for nicotine following application of NTS for 24 h were 7.7 and 4.2 h, respectively. 3. Following NTS removal, the mean apparent nicotine elimination half-life was 2.8 h, compared with 2.0 h following i.v. nicotine, reflecting continued absorption of nicotine following NTS removal. 4. The mean amount of nicotine absorbed from the NTS after the 24 h application was 20.9 mg, which represents about 68% of the amount released from the system; the remaining 32% was lost from the system during daily activities. 5. The ratio of AUC values for the metabolite cotinine relative to nicotine was similar whether nicotine was administered transdermally or intravenously. 6. Following i.v. administration, the mean nicotine clearance was 72 l h-1 (coefficient of variation 29%). Since coefficients of variation in AUC values following NTS and i.v. treatments were similar, transdermal administration of nicotine was not associated with increased interindividual variability in plasma nicotine concentrations. 7. No significant changes were seen in the pharmacokinetics of nicotine between single and multiple applications of NTS. 8. As expected from the higher total plasma nicotine concentrations, the incidence of adverse effects was higher following simultaneous intravenous and transdermal administration of nicotine. The most frequently reported systemic side effects were nervousness and headache: mild itching was the most frequent topical effect.
机译:1.在单次或多次应用尼古丁透皮系统(NTS)后,在13名健康成年男性吸烟者中研究了尼古丁的绝对生物利用度和吸收动力学,该系统设计为在24小时内以1.5 mg h-1的速率释放尼古丁。参考氘标记的尼古丁的同时静脉输注(i.v.),计算单次NTS施用中尼古丁的吸收。 2.应用NTS 24小时后,尼古丁的平均输入时间(MIT)和平均吸收时间(MAT)分别为7.7和4.2 h。 3.去除NTS后,平均烟碱清除半衰期为2.8小时,而静脉注射后为2.0小时。尼古丁,反映了NTS去除后尼古丁的持续吸收。 4.施用24小时后,从NTS吸收的尼古丁平均量为20.9 mg,约占系统释放量的68%。其余的32%在日常活动中从系统中丢失。 5.无论是经皮或静脉内施用烟碱,代谢产物可替宁的AUC值相对于烟碱的比率均相似。 6.在i.v.之后服用尼古丁的平均清除率为72 l h-1(变异系数为29%)。由于遵循NTS和i.v的AUC值的变化系数。治疗方法相似,尼古丁的透皮给药与血浆尼古丁浓度的个体间差异增加无关。 7.在一次和多次使用NTS之间,尼古丁的药代动力学未见明显变化。 8.从更高的血浆总烟碱浓度可以预期,同时静脉内和经皮给予烟碱后,不良反应的发生率更高。最常见的全身性副作用是神经质和头痛:轻度瘙痒是最常见的局部副作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号